156 related articles for article (PubMed ID: 33376540)
1. Anillin is a prognostic factor and is correlated with genovariation in pancreatic cancer based on databases analysis.
Nie Y; Zhao Z; Chen M; Ma F; Fan Y; Kang Y; Kang B; Wang C
Oncol Lett; 2021 Feb; 21(2):107. PubMed ID: 33376540
[TBL] [Abstract][Full Text] [Related]
2. ANLN is a prognostic biomarker independent of Ki-67 and essential for cell cycle progression in primary breast cancer.
Magnusson K; Gremel G; Rydén L; Pontén V; Uhlén M; Dimberg A; Jirström K; Pontén F
BMC Cancer; 2016 Nov; 16(1):904. PubMed ID: 27863473
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of Anillin (ANLN) is correlated with colorectal cancer progression and poor prognosis.
Wang G; Shen W; Cui L; Chen W; Hu X; Fu J
Cancer Biomark; 2016; 16(3):459-65. PubMed ID: 27062703
[TBL] [Abstract][Full Text] [Related]
4. Collagen type VII α1 chain: A promising prognostic and immune infiltration biomarker of pancreatic cancer.
Ding C; Yu Z; Li X; Zhu J; Dai M; He Q
Oncol Lett; 2023 Feb; 25(2):77. PubMed ID: 36742365
[TBL] [Abstract][Full Text] [Related]
5. Multi-omics analyses based on genes associated with oxidative stress and phospholipid metabolism revealed the intrinsic molecular characteristics of pancreatic cancer.
Wang H; Guo H; Sun J; Wang Y
Sci Rep; 2023 Aug; 13(1):13564. PubMed ID: 37604837
[TBL] [Abstract][Full Text] [Related]
6. Clinical implication and immunological landscape analyses of ANLN in pan-cancer: A new target for cancer research.
Zhang L; Wei Y; He Y; Wang X; Huang Z; Sun L; Chen J; Zhu Q; Zhou X
Cancer Med; 2023 Feb; 12(4):4907-4920. PubMed ID: 36030492
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of ANLN in lung adenocarcinoma.
Long X; Zhou W; Wang Y; Liu S
Oncol Lett; 2018 Aug; 16(2):1835-1840. PubMed ID: 30008873
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive bioinformatics analysis reveals the prognostic value, predictive value, and immunological roles of ANLN in human cancers.
Cui Z; Mo J; Song P; Wang L; Wang R; Cheng F; Wang L; Zou F; Guan X; Zheng N; Yang X; Wang W
Front Genet; 2022; 13():1000339. PubMed ID: 36199577
[TBL] [Abstract][Full Text] [Related]
9. Regulation of actin-binding protein ANLN by antitumor
Idichi T; Seki N; Kurahara H; Yonemori K; Osako Y; Arai T; Okato A; Kita Y; Arigami T; Mataki Y; Kijima Y; Maemura K; Natsugoe S
Oncotarget; 2017 Aug; 8(32):53180-53193. PubMed ID: 28881803
[TBL] [Abstract][Full Text] [Related]
10. A two-gene-based prognostic signature for pancreatic cancer.
Zhou S; Yan Y; Chen X; Zeng S; Wei J; Wang X; Gong Z; Xu Z
Aging (Albany NY); 2020 Sep; 12(18):18322-18342. PubMed ID: 32966237
[TBL] [Abstract][Full Text] [Related]
11. Transcriptome sequencing identifies ANLN as a promising prognostic biomarker in bladder urothelial carcinoma.
Zeng S; Yu X; Ma C; Song R; Zhang Z; Zi X; Chen X; Wang Y; Yu Y; Zhao J; Wei R; Sun Y; Xu C
Sci Rep; 2017 Jun; 7(1):3151. PubMed ID: 28600503
[TBL] [Abstract][Full Text] [Related]
12. Bioinformatic Analysis of Prognostic and Immune-Related Genes in Pancreatic Cancer.
Li Z; Hu C; Yang Z; Yang M; Fang J; Zhou X
Comput Math Methods Med; 2021; 2021():5549298. PubMed ID: 34394706
[TBL] [Abstract][Full Text] [Related]
13. ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p/LASP1 signaling axis.
Wang A; Dai H; Gong Y; Zhang C; Shu J; Luo Y; Jiang Y; Liu W; Bie P
J Exp Clin Cancer Res; 2019 Aug; 38(1):347. PubMed ID: 31395079
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of anillin is related to poor prognosis in patients with hepatocellular carcinoma.
Zhang LH; Wang D; Li Z; Wang G; Chen DB; Cheng Q; Hu SH; Zhu JY
Hepatobiliary Pancreat Dis Int; 2021 Aug; 20(4):337-344. PubMed ID: 32933876
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive Analysis of ANLN in Human Tumors: A Prognostic Biomarker Associated with Cancer Immunity.
Zhang X; Li L; Huang S; Liao W; Li J; Huang Z; Huang Y; Lian Y
Oxid Med Cell Longev; 2022; 2022():5322929. PubMed ID: 35340220
[TBL] [Abstract][Full Text] [Related]
16. Over-Expression of Alpha-Enolase as a Prognostic Biomarker in Patients with Pancreatic Cancer.
Sun L; Guo C; Cao J; Burnett J; Yang Z; Ran Y; Sun D
Int J Med Sci; 2017; 14(7):655-661. PubMed ID: 28824297
[No Abstract] [Full Text] [Related]
17. Subcellular localisation of anillin is associated with different survival outcomes in upper urinary tract urothelial carcinoma.
Liang PI; Chen WT; Li CF; Li CC; Li WM; Huang CN; Yeh HC; Ke HL; Wu WJ; Chai CY
J Clin Pathol; 2015 Dec; 68(12):1026-32. PubMed ID: 26135313
[TBL] [Abstract][Full Text] [Related]
18. High expression of MMP28 indicates unfavorable prognosis in pancreatic cancer.
Chen Z; Huang J; Li M; Zhang L; Wan D; Lin S
Medicine (Baltimore); 2021 Mar; 100(12):e25320. PubMed ID: 33761734
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive analyses reveal the carcinogenic and immunological roles of ANLN in human cancers.
Shi Y; Ma X; Wang M; Lan S; Jian H; Wang Y; Wei Q; Zhong F
Cancer Cell Int; 2022 May; 22(1):188. PubMed ID: 35568883
[TBL] [Abstract][Full Text] [Related]
20. Screening
Yang T; Chi Z; Liu G; Hong X; Cao S; Cheng K; Zhang Y
Front Genet; 2023; 14():1107625. PubMed ID: 37051591
[No Abstract] [Full Text] [Related]
[Next] [New Search]